GlassScriptPhysician profile
Adam Stein
NPI 1538515176
$42,395.50
in general payments reported to CMS, 2019-2025
28 companies · $9,039 in 2025
The $9,039 reported for 2025 was more than what 90% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,684 · 2022: $4,816 · 2023: $6,511 · 2024: $16K · 2025: $9,039.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $28K · Food and Beverage: $3,820 · Travel and Lodging: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $27,555.56 |
| Food and Beverage | $3,820.40 |
| Travel and Lodging | $519.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $27,576.86 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $11,265.91 | 2021-2025 | Turbohawk, Endurant Iis, Ellipsys Vascular Access System |
| W. L. Gore & Associates, INC. | $801.87 | 2021-2023 | Gore Tag Thoracic Branch Endoprosthesis |
| Boston Scientific Corporation | $531.71 | 2023-2025 | Eluvia, Enroute Transcarotid Neuroprotection System, Varithena Administration Pack |
| Endologix LLC | $374.27 | 2022-2024 | Torus Stent Graft System, Endocross Device, Afx2 Bifurcated Endograft System |
| Mimedx Group, INC. | $228.94 | 2024 | |
| Silk Road Medical, INC. | $226.25 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Tactile Systems Technology INC | $166.57 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Penumbra, INC. | $158.01 | 2022-2025 | Penumbra System |
| Lemaitre Vascular, INC. | $148.87 | 2023-2025 | Hydro Lemaitre Valvulotome, Artegraft Vascular Graft, Restoreflow |
| Janssen Pharmaceuticals, INC | $146.08 | 2023-2024 | Xarelto |
| Saluda Medical Americas, INC. | $130.42 | 2025 | Evoke |
| Stryker Corporation | $130.39 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $72.65 | 2023-2024 | Eliquis |
| Shockwave Medical, INC | $65.56 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $45.88 | 2023-2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Next Science LLC | $43.79 | 2023 | Xperience, Blastx, Surgx |
| Cordis US Corp. | $43.65 | 2023-2024 | Radial 360, Mynx Venous Vcd |
| Philips North America LLC | $43.49 | 2021 | |
| Baxter Healthcare | $30.67 | 2021 | |
| Pfizer INC. | $25.12 | 2025 | |
| Convatec INC. | $24.63 | 2025 | |
| Polynovo North America LLC | $24.45 | 2025 | Novosorb Btm |
| Koya Medical, INC. | $21.72 | 2025 | Dayspring, Koya Medical |
| Centerline Biomedical INC. | $21.42 | 2022 | |
| Reprise Biomedical, INC. | $18.29 | 2024 | Miro3d |
| Inari Medical, INC. | $14.20 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $13.83 | 2025 | Stravix, Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.